We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bone Harvesting Device to Reduce Post-Spinal Fusion Pain

By HospiMedica staff writers
Posted on 21 Jul 2003
A new, minimally invasive technique for collecting bone marrow cells from the hip to treat back pain is designed to reduce the hip pain that can follow spinal fusion surgery.

Spinal fusion surgery is used to relieve back pain caused by a damaged disc. More...
In the accompanying traditional bone harvesting, surgeons remove bone material from a patient's hip area through a three- to five-inch incision. Studies have shown that complications follow 31% of these procedures and that 27% of patients continue to feel pain in the hip area as long as two years after surgery.

The new technique utilizes a device called Cellect, which employs a needle to collect bone marrow cells from the hip area and then processes the cells so they can be grafted onto the spine. This technique may result in fewer complications and also reduce hip pain. The Cellect aspiration needle extracts bone marrow through a tiny incision. The marrow is then placed into the Cellect System, which enriches the graft with an increased proportion of progenitor cells onto a special matrix through a patented process. The cells are then inserted into the spine operative area. The technology was developed by DePuy AcroMed (Raynham, MA, USA), in collaboration with The Cleveland Clinic Foundation (OH, USA).

"This new technology will also serve as a key platform for us as we develop other products that enhance spine surgery and improve the quality of life for the millions of people who suffer from painful spine and back conditions,” said Earl R. Fender, president of DePuy AcroMed, Inc.





Related Links:
DePuy AcroMed
Cleveland Clinic

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.